49 studies found for:    " January 30, 2008":" February 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" January 30, 2008":" February 29, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (49 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Terminated
Has Results
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
2 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
3 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine
4 Completed Yoga for the Management of HIV-Metabolic Syndromes
Conditions: HIV Infections;   HIV Metabolic Cardiovascular Syndrome;   HIV Lipodystrophy;   HIV Metabolic Syndromes;   Hypertension
Interventions: Behavioral: Yoga lifestyle intervention;   Other: Standard of care
5 Completed
Has Results
The Effect of Raltegravir on HIV Decay During Primary and Chronic Infection
Condition: HIV Infection
Intervention: Drug: Tenofovir + emtricitabine  + raltegravir.
6 Completed Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
Condition: HIV Infections
Intervention: Procedure: Male Circumcision
7 Completed
Has Results
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada;   Other: Placebo
8 Terminated Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: EnvDNA, PolyEnv1, EnvPro
9 Completed Experimental Design of Couple Counseling and Testing in Antenatal Clinics in Dar es Salaam, Tanzania
Condition: HIV Infections
Interventions: Behavioral: Couples VCT;   Behavioral: Individual VCT
10 Completed Early Versus Delayed Routine HIV Testing in Connecticut Jails
Condition: HIV Infections
Intervention: Other: routine HIV testing
11 Active, not recruiting Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Conditions: HIV Infections;   Staphylococcal Infections
Interventions: Drug: Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3%;   Drug: Placebo
12 Completed Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women
Conditions: Pregnancy;   HIV Infections;   Sexually Transmitted Diseases
Interventions: Behavioral: CenteringPregnancy Plus (CP+);   Behavioral: Usual care
13 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
14 Active, not recruiting Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
15 Completed A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
Condition: HIV Infections
Interventions: Drug: Dapivirine Gel 4750, 0.05%, 2.5g;   Drug: Dapivirine Gel 4789, 0.05%, 2.5g;   Drug: HEC-based Placebo Gel
16 Completed
Has Results
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
17 Unknown  Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
18 Completed Naïve HIV POC Monotherapy Trial
Condition: HIV Infections
Interventions: Drug: RDEA806 400 mg;   Drug: Placebo;   Drug: RDEA806 1000 mg;   Drug: RDEA806 600 mg;   Drug: RDEA806 800 mg
19 Completed
Has Results
Raltegravir Intensification in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Placebo
20 Completed Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years